Understanding the genesis of psychotic disorder: Issues in the prediction and prophylaxis of those at 'ultra-high risk'

British Journal of Clinical Psychology

Volumn 44, Issue 3, 2005, Pages 383-404

  Mason, Oliver J ^a   Beavan Pearson, Julie ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

ADOLESCENCE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; MEDICAL ETHICS; NEUROPSYCHOLOGY; PATHOGENESIS; PERSONALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SIDE EFFECT; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; STRESS;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; COGNITION; HUMANS; MODELS, PSYCHOLOGICAL; PERSONALITY; PSYCHOTIC DISORDERS; RISK FACTORS; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 26844509300     PISSN: 01446657     EISSN: None     Source Type: Journal    
DOI: 10.1348/014466505X34615     Document Type: Review

References (134)

1. Allen, D. N., Kelley, M. E., Miyatake, R. K., Gurklis, J. A., & van Kammen, D. P. (2001). Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia. Schizophrenia Bulletin, 27, 39-46.
2. Arsenault, L., Cannon, M., Witton, J., & Murray, R. M. (2004). Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry, 184, 110-117.
3. Asarnow, J. R., & Goldstein, M. J. (1986). Schizophrenia during adolescence and early adulthood: A developmental perspective. Clinical Psychology Review, 6, 211-235.
4. Bentall, R. P., Jackson, H. F., & Pilgrim, D. (1988). Abandoning the concept of schizophrenia: Some implications of validity arguments for psychological research into psychotic phenomena. British Journal of Clinical Psychology, 27, 303-324.
5. Bleuler, E. (1911). Dementia praecox or the group of schizophrenias. New York: International Universities Press.
6. Bowers, M. B., & Freedman, D. X. (1966). Psychedelic experiences in acute psychoses. Archives of General Psychiatry, 15, 240-248.
7. Cameron, D. E. (1938). Early schizophrenia. American Journal of Psychiatry, 95, 567-578.
8. Cannon, M., Walsh, E., Hollis, C., Kargin, M., Taylor, E., Murray, R. M., & Jones, P. B. (2001). Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. British Journal of Psychiatry, 178, 420-426.
9. Carpenter, W. T., Jr,. & Kirkpatrick, B. (1988). The heterogeneity of the long-term course of schizophrenia. Schizophrenia Bulletin, 14, 645-652.
10. Carr, V., Halpin, S., Lau, N., O'Brien, S., Beckmann, J., & Lewin, T. (2000). A risk factor screening and assessment protocol for schizophrenia and related psychosis. Australian and New Zealand Journal of Psychiatry, 34(Supp.1), S170-S180.
11. Chapman, J. P. (1966). The early symptoms of schizophrenia. British Journal of Psychiatry, 112, 225-251.
12. Chapman, L.J., & Chapman, J. P. (1980). Scales for rating psychotic and psychotic-like experiences as continua. Schizophrenia Bulletin, 6, 476-489.
13. Chapman, L. J., & Chapman, J. P. (1987). The search for symptoms predictive of schizophrenia. Schizophrenia Bulletin, 13(3), 497-503.
14. Chapman, L. J., Chapman, J. P., Kwapil, T. R., Eckblad, M., & Zinser, M. C. (1994). Putatively psychosis-prone subjects 10 years later. Journal of Abnormal Psychology, 103, 171-183.
15. Chen, W. J., Hsiao, C. K., & Lin, C. C. (1997). Schizotypy in community samples: The three-factor structure and correlation with sustained attention. Journal of Abnormal Psychology, 106(4), 649-654.
16. Chiridge, G. S. (1985). The origins of mental illness. Oxford: Blackwell.
17. Cornblatt, B. A., & Keilp, J. G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20, 31-46.
18. Cornblatt, B. A., Lencz, T., & Kane, J. M. (2001). Treatment of the schizophrenia prodrome: Is it presently ethical? Schizophrenia Research, 51, 31-38.
19. Cornblatt, B., Lencz, T., & Obuchowski, M. (2002). The schizophrenia prodrome: Treatment and high-risk perspectives. Schizophrenia Research, 54, 177-186.
20. Cornblatt, B., Obuchowski, M., Roberts, S., Pollack, S., & Erlenmeyer-Kimling, L. (1999). Cognitive and behavioral precursors of schizophrenia. Development and Psychopathology, 11, 487-508.
21. Crockett, M. S. (1988). Self-reports of childhood peer relationships of psychiatric and nonpsychiatric subjects. Issues in Mental Health Nursing, 9, 45-71.
22. Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z., & Mark, M. (1999). Behavioral and intellectual markers in apparently healthy mate adolescents. American Journal of Psychiatry, 156, 1328-1335.
23. Docherty, J. P., van Kammen, D. P., Siris, S. G., & Marder, S. R. (1978). Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135, 420-426.
24. Done, D. J., Crow, T. J., Johnstone, E. C., & Sacker, A. (1994). Childhood antecedents of schizophrenia and affective illness: Social adjustment at ages 7 and 11. British Medical Journal, 309, 699-703.
25. Drake, R., & Wallach, M. (1989). Substance abuse among the chronically mentally ill. Hospital and Community Psychiatry, 40, 1041-1046.
26. Erlenmeyer-Kimling, L., & Cornblatt, B. (1987). High-risk research in schizophrenia: A summary of what has been learned. Journal of Psychiatric Research, 21(4), 401-411.
27. Erlenmeyer-Kimling, L., Rock, D., Roberts, S. A., Janal, M., Kestenbaum, C., Cornblatt, B., Hilldoff Adamo, U., & Gottesman, I. I. (2000). Attention, memory and motor skills as childhood predictors of schizophrenia-related psychoses: The New York high-risk project. American Journal of Psychiatry, 157, 1416-1422.
28. Fenton, W. S., & McGlashan, T. H. (1989). Risk of schizophrenia in character disordered patients. American Journal of Psychiatry, 146(10), 1280-1284.
29. Gottesman, I. I. (1991). Schizophrenia genesis: The origin of madness. New York: Freeman.
30. Gottesman, I. I., & Erlenmeyer-Kimling, L. (2001). Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia. Schizophrenia Research, 51, 93-102.
31. Gottesman, I. I., & Shields, J. (1982). Schizophrenia: The epigenetic puzzle. Cambridge: Cambridge University Press.
32. Gross, G. (1989). The basic symptoms of schizophrenia. British Journal of Psychiatry, 155(Suppl. 7), 21-25.
33. Gross, G., & Huber, G. (1998). Prodromes and primary prevention of schizophrenic psychoses. Neurology, Psychiatry and Brain Research, 6, 51-58.
34. Gross, G., Huber, G., & Klosterkotter, J. (1992). Early diagnosis of schizophrenia. Neurology, Psychiatry and Brain Research, 6, 51-58.
35. Hafner, H., Loffler, W., Maurer, K., Hambrecht, M., & van der Heiden (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100(2), 105-118.
36. Hafner, H., Riecher-Rossler, A., Hambrecht, M., Maurer, K., Meissner, S., Schmidtke, A., Fatkenheurer, B., Loffler, W., & van der Heiden, W. (1992). IRAOS: An instrument for the assessment of onset and early course in schizophrenia. Schizophrenia Research, 6, 209-223.
37. Hafner, H., & van der Heiden, W. (1997). Epidemiology of schizophrenia. Canadian Journal of Psychiatry, 42, 139-151.
38. Hall, W., & Degenhardt, L. (2000). Cannabis use and psychosis: A review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 34, 26-34.
39. Hambrecht, M., & Hafner, H. (2000). Cannabis, vulnerability, and the onset of schizophrenia: An epidemiological perspective. Australian and New Zealand Journal of Psychiatry, 34, 468-475.
40. Hambrecht, M., Lammertink, M., Klosterkotter, J., Matuschek, E., & Pukrop, R. (2002). Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. British Journal of Psychiatry, 181(Suppl. 43), S30-S37.
41. Henquet, C., Krabbendam, L., Spauwen, J., Lieb, R., Wittchen, H. U., & van Os, J. (2004). Cannabis use and psychosis in adolescents and young adults. Schizophrenia Research, 61(1), 217.
42. Huber, G., Gross, G., Schuttler, R., & Linz, M. (1980). Longitudinal studies of schizophrenic patients. Schizophrenia Bulletin, 6(4), 592-605.
43. Huttunen, M., Machon, R. A., & Mednick, S. A. (1994). Prenatal factors in the pathogenesis of schizophrenia. British Journal of Psychiatry, 164(Suppl. 23), 15-19.
44. Jackson, H. J., McGorry, P. D., & Dudgeon, P. (1995). Prodromal symptoms of schizophrenia in first-episode psychosis: Prevalence and specificity. Comprehensive Psychiatry, 36, 241-250.
45. Jarboe, K. S., & Kilts, C. (1998). Diagnosis, neurobiology, and treatment of first-episode schizophrenia. Journal of the American Psychiatric Nurses Association, 4(1), S2-S9.
46. Johns, L., & van Os, J. (2001). The continuity of psychotic experiences in the general population. Clinical Psychology Review, 21, 1125-1141.
47. Jones, P. B. (2000). Population birth cohorts: Antecedents of schizophrenia. European Psychiatry, 15(Suppl. 2), 213.
48. Jones, P., Rantakallio, P., Hartikainen, A. -L., Isohanni, M., & Sipila, P. (1998). Schizophrenia as a long-term outcome of pregnancy, delivery and perinatal complications: A 28-year follow-up of the 1966 Northern Finland general population birth cohort. American Journal of Psychiatry, 155, 355-364.
49. Jones, P., Rodgers, B., Murray, R., & Marmot, M. (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398-1402.
50. Keith, S. J., & Matthews, S. M. (1991). The diagnosis of schizophrenia: A review of onset and duration issues. Schizophrenia Bulletin, 17(1), 51-67.
51. Kendler, K. S., & Gardner, C. O. (1997). The risk for psychiatric disorders in relatives of schizophrenic and control probands: A comparison of three independent studies. Psychological Medicine, 27, 411-419.
52. Kendler, K. S., McGuire, M., Gruenberg, A. M., & Walsh, D. (1995). Schizotypal symptoms and signs in the Roscommon family study: Their factor structure and familial relationship with psychotic and affective disorders. Archives of General Psychiatry, 52, 296-303.
53. Keshavan, M. S., & Schooler, N. R. (1992). First-episode studies in schizophrenia: Criteria and characterization. Schizophrenia Bulletin, 18(3), 491-513.
54. Klosterkotter, J. (1992). The meaning of basic symptoms for the development of schizophrenic psychoses. Neurology, Psychiatry and Brain Research, 1, 30-41.
55. Klosterkotter, J., Ebel, H., Schultze-Lutter, F., & Steinmeyer, E. M. (1996). Diagnostic validity of basic symptoms. European Archives of Psychiatry and Clinical Neuroscience, 246, 147-154.
56. Klosterkotter, J., Gross, G., Huber, G., Wieneke, A., Steinmeyer, E. M., & Schultze-Lutter, F. (1997). Evaluation of the bonn scale for the assessment of basic symptoms-BSABS as an instrument for the assessment of schizophrenia proneness: A review of recent findings. Neurology, Psychiatry and Brain Research, 5, 137-150.
57. Klosterkotter, J., Hellmich, M., Steinmeyer, E. M., & Schultze-Lutter, F. (2001). Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158-164.
58. Klosterkotter, J., Schultze-Lutter, F., Gross, G., Huber, G., & Steinmeyer, E. M. (1997). Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: An 8-year average follow-up prospective study. Acta Psychiatrica Scandinavica, 95, 396-404.
59. Kraepelin, E. (1904). Clinical psychiatry: A text-book for students and physicians. New York: Macmillan.
60. Krausz, M., & Muller-Thomsen, T. S. O. (1993). Schizophrenia with onset in adolescence: An 11-year follow-up. Schizophrenia Bulletin, 19, 831-841.
61. Kremen, W. S., Seidman, L. J., Pepple, J. R., Lyons, M. J., Tsuang, M. T., & Faraone, S. V. (1994). Neuropsychological risk indicators for schizophrenia: A review of family studies. Schizophrenia Bulletin, 20, 103-119.
62. Kretschmer, E. (1936). Physique and character. London: Kegan Paul, Trench Trubner.
63. Larsen, T. K., Friis, S., Haahr, U., Joa, I., Johannessen, J. O., Melle, I., Opjordsmoen, S., Simonsen, E., & Vaglum, P. (2001). Early detection and intervention in first-episode schizophrenia: A critical review. Acta Psychiatrica Scandinavica, 103, 323-334.
64. Larsen, T. K., McGlashan, T. H., & Moe, L. C. (1996). First-episode schizophrenia: I. Early course parameters. Schizophrenia Bulletin, 22, 241-256.
65. Linney, Y., Murray, R., Peters, E., MacDonald, A., & Rijsdijk, S. (2003). A quantitative genetic analysis of schizotypal personality traits. Psychological Medicine, 33, 803-816.
66. Malla, A. K., & Norman, R. M. G. (1999). Facing the challenges of intervening early in psychosis. Annales of the Royal College of Physician and Surgeons, 32, 394-397.
67. Malla, A. M., & Norman, R. M. G. (2001). Treating psychosis: Is there more to early intervention than intervening early? Canadian Journal of Psychiatry, 46, 645-648.
68. Malmberg, A., Lewis, G., David, A., & Allebeck, P. (1998). Premorbid adjustment and personality in people with schizophrenia. British Journal of Psychiatry, 172, 308-313.
69. Mason, O., Startup, M., Halpin, S., Schall, U., Conrad, A., & Carr, V. (2004). Risk factors for transition to first episode psychosis among individuals with at risk mental states. Schizophrenia Research, 71, 227-237.
70. McGlashan, T. H. (1986). Schizophrenia: Psychosocial therapies and the role of psychosocial factors in its etiology and pathogenesis. In A. J. Frances & R. E. Hales (Eds.), American Psychiatric Association Annual Review (Vol. V, pp. 96-111). Washington, DC: American Psychiatric Press.
71. McGlashan, T. H. (1996). Early detection and intervention in schizophrenia: Research. Schizophrenia Bulletin, 22(2). 327-345.
72. McGlashan, T. (1999). Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biological Psychiatry, 46, 899-907.
73. McGlashan, T. H. (2000). Treating schizophrenia earlier in life and the potential for prevention. Current Psychiatry Reports, 2, 386-392.
74. McGlashan, T. H. (2001). Psychosis treatment prior to psychosis onset: Ethical issues. Schizophrenia Research, 51, 47-54.
75. McGlashan, T. H., & Johannessen, J. O. (1996). Early detection and intervention with schizophrenia: Rationale. Schizophrenia Bulletin, 22(2), 201-222.
76. McGlashan, T. H., Miller, T. J., & Woods, S. W. (2001). Pre-onset detection and intervention research in schizophrenic psychoses: Current estimates of benefit and risk. Schizophrenia Bulletin, 27(4), 563-570.
77. McGlashan, T., Zipursky, R., Perkins, D., Addington, J., Miller, T., Woods, S., Hawkins, K., Hoffman, K., Tohen, M., & Breier, A. (2004). Pharmacotherapy in the prodromal phase of first psychosis: Results and complications. Schizophrenia Research, 76(1), 6 (Suppl. S).
78. McGorry, P. D. (1998). A stitch in time ... the scope for preventative strategies in early psychosis. European Archives of Psychiatry and Clinical Neuroscience, 248, 22-31.
79. McGorry, P. D. (2000). The nature of schizophrenia: Signposts to prevention. Australian and New Zealand Journal of Psychiatry, 34(Suppl.), S14-S21.
80. McGorry, P. & Curry, C. (1999). Cannabis use as a risk factor for development of psychotic symptoms: A prospective study. Inaugural International Cannabis and Psychosis Conference, Melbourne, 16-17 February 1999.
81. McGorry, P. & Jackson, H. (Eds.). (1999). The recognition and management of early psychosis: A preventative approach. Cambridge: Cambridge University Press.
82. McGorry, P. D., Krstev, H., & Harrigan, S. (2000). Early detection and treatment delay: Implications for outcome in early psychosis. Current Opinion in Psychiatry, 13, 37-43.
83. McGorry, P. D., McFarlane, C., Patton, G. C., Bell, R., Hibbert, M. E., Jackson, H. J., & Bowes, G. (1995). The prevalence of prodromal features of schizophrenia in adolescence: A preliminary survey. Acta Psychiatrica Scandinavica, 92, 241-249.
84. McGorry, P. D., McKenzie, D., Jackson, H. J., Waddell, F., & Curry, C. (2000). Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia? Schizophrenia Research, 42, 91-100.
85. McGorry, P., Phillips, L., Trapman, I., O'Dwyer, L., Koutsogiannis, J., Leicester, S., Francey, S., Amminger, P., Ward, J., Jones, S., & Kelly, M. (2002). Needles in a haystak: Finding the ultra high risk (prodromal) patients. Schizophrenia Research, 53(3). 5 (Sp. ISS. S1. Suppl.s).
86. McGorry, P. D., & Singh, B. S. (1995). Schizophrenia: Risk and possibility. In B. Raphael & G. D. Burrows (Eds.), Handbook of preventative psychiatry (pp. 492-514). New York: Elsevier.
87. McGorry, P. D., Yung, A., & Phillips, L. (2001). Ethics and early intervention in psychosis: Keeping up the pace and staying in step. Schizophrenia Research, 51, 17-29.
88. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., & Jackson, H. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921-928.
89. McNeil, T. F., Cantor-Graae, E., & Sjostrom, K. (1994). Obstetric complications as antecedents of schizophrenia: Empirical effects of using different obstetric complication scales. Journal of Psychiatric Research, 28, 519-530.
90. Meares, A. (1959). The diagnosis of pre-psychotic schizophrenia. Lancet, 1, 55-59.
91. Miller, T. J., & McGlashan, T. H. (2000). Early identification and intervention in psychotic illness. Connecticut Medicine, 64(6), 339-341.
92. Miller, T. J., McGlashan, T. H., & Rosen, J. L. (2001). Diagnosis and symptom assessment in the schizophrenia prodrome: Psychometrics from the PRIME research centre. Schizophrenia Research, 49(Suppl. 1-2), 6.
93. Miller, T., McGlashan, T. H., Rosen, J. L., Somjee, L., Markovich, P., Stein, K., & Woods, S. (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: Preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry, 15-9(5), 863-865.
94. Miller, T. J., McGlashan, T. H., Woods, S. W., Stein, K., Driesen, N., Corcoran, C. M., Hoffman, R., & Davidson, L. (1999). Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly, 70, 273-287.
95. Moller, P., & Husby, R. (2000). The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behaviour. Schizophrenia Bulletin, 26(1), 217-232.
96. Morrison, A. P., Bentall, R. P., French, P., Watford, L., Kilcommons, A.,Knight, A., Kreutz, M., & Lewis, S. W. (2002). Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry, 181(Suppl. 43), S78-S84.
97. Mrazek, P. J. & Haggerty, R. J. (Eds.). (1994). Reducing risks for mental disorders: Frontiers for preventive intervention research. Washington: National Academy Press.
98. Mueser, K., Bellack, A., & Blanchard, J. (1992). Comorbidity of schizophrenia and substance abuse: Implications for treatment. Journal of Consulting and Clinical Psychology, 60, 845-856.
99. Nuechterlein, K. H., & Dawson, M. E. (1984). A heuristic vulnerability/stress model of schizophrenic episodes. Schizophrenia Bulletin, 10, 300-312.
100. Nuechterlein, K. H., Dawson, M. E., Gitlin, M., Ventura, J., Goldstein, M. J., Snyder, K. S., Yee, C. M., & Mintz, J. (1992). Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin, 18(3), 387-425.
101. Nuechterlein, K. H., Dawson, M. E., Ventura, J., Gitlin, M., Subotnik, K. L., Snyder, K. S., Mintz, J., & Bartzokis, G. (1994). The vulnerability/stress model of schizophrenic relapse: A longitudinal study. Acla Psychiatrica Scandinavica, 8-9(Suppl. 382), 58-64.
102. Olin, S. S., John, R. S., & Mednick, S. A. (1995). Assessing the predictive value of teacher reports in a high risk sample for schizophrenia: An ROC analysis. Schizophrenia Research, 16, 53-66.
103. Olin, S. C., & Mednick, S. A. (1996). Risk factors of psychosis: Identifying vulnerable populations premorbidly. Schizophrenia Bulletin, 22, 223-240.
104. Parnas, J., Cannon, T. D., Jacobsen, B., Schulsinger, H., Schulsinger, F., & Mednick, S. (1993). Lifetime DSM-III-R diagnostic outcomes in the off-springs of schizophrenic mothers. Archives of General Psychiatry, 50, 707-714.
105. Parnas, J., Jansson, L., Sass, L. A., & Handest, P. (1998). Self-experience in the prodromal phases of schizophrenia: A pilot study of first-admissions. Neurology, Psychiatry and Brain Research, 6, 97-106.
106. Parnas, J., & Mednick, S. A. (1991). Early predictors of onset and course of schizophrenia and schizophrenia spectrum. In H. Hafner & W. F. Gattaz (Eds.), Search for the causes of schizophrenia, (Vol. II, pp. 34-47). Berlin: Springer-Verlag.
107. Phillips, L. J., Curry, C., & Yung, A. R. (2002). Cannabis use is not associated with the development of psychosis in a high risk group. Australian and New Zealand Journal of Psychiatry, 36, 800-806.
108. Phillips, L., Yung, A., Hearn, N., McFarlane, C., Hallgren, M., & McGorry, P. (1999). Preventative mental health care: Accessing the target population. Australian and New Zealand Journal of Psychiatry, 33, 912-917.
109. Poulton, R., Caspi, A., Moffitt, T. E., Cannon, M., Murray, R., & Harrington, H. L. (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Archives of General Psychiatry, 57, 1053-1058.
110. Rantakallio, P., Jones, P., Moring, J., & von Wendt, L. (1997). Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: A 28-year follow-up. International Journal of Psychiatry, 26, 837-843.
111. Rao, R. (2001). Cannabis: Some psychiatric aspects. Primary Care Psychiatry, 7(3), 101-105.
112. Schneider, K. (1958). Psychopathic personalities. London: Cassell.
113. Shaffener, K., & McGorry, P. D. (2001). Preventing severe mental illnesses - new prospects and ethical challenges. Schizophrenia Research, 51, 3-15.
114. Simon, A. E., Ferrero, F. P., & Merto, M. C. G. (2001). Prodromes of first-episode psychosis: How can we challenge nonspecificity? Comprehensive Psychiatry, 42(5), 382-392.
115. Strauss, J. S. (1969). Hallucinations and delusions as points on continua functions. Archives of General Psychiatry, 21, 581-586.
116. Sullivan, H. S. (1927). The onset of schizophrenia. American Journal of Psychiatry, 6, 105-134.
117. Thompson, K. N., McGorry, P. D., Phillips, L. J., & Yung, A. R. (2001). Prediction and intervention in the pre-psychotic phase. Journal of Advances in Schizophrenia and Brain Research, 3(2), 43-47.
118. Tienari, P., Sorri, A., Lahti, I., Naarala, M., Wahlberg, K. E., Ronkkot Pohjola, J., & Moring, J. (1985). The finnish adoptive family study of schizophrenia. Yale Journal of Biological Medicine, 58, 227-237.
119. Tienari, P., Wynne, L. C., Moring, J., Lahti, I., Naarala, M., Sorri, A., Wahlberg, K. E., Saarento, O., Seitamma, M., & Kaleva, M. (1994). The finnish adoptive family study of schizophrenia: Implications for family research. British Journal of Psychiatry, 164, 20-26.
120. Timbury, G. C., & Mowbray, R. M. (1964). The diagnosis of schizophrenia by Scottish psychiatrists. British Journal of Psychiatry, 110, 174-180.
121. Tsuang, M. T., Stone, W. S., & Faraone, S. V. (2001). Genes, environment and schizophrenia. British Journal of Psychiatry, 178(Suppl. 40), S18-S24.
122. Vaglum, P. (1996). Earlier detection and intervention in schizophrenia: Unsolved questions. Schizophrenia Bulletin, 22(2), 347-351.
123. Varsamis, J., & Adamson, J. D. (1971). Early schizophrenia. Canadian Psychiatric Association Journal, 16, 487-497.
124. Wahlberg, K-E., & Wynne, L. C. (2001). Possibilities for prevention of schizophrenia. Suggestions from research on genotype-environment interaction. International Journal of Mental Health, 30(1), 91-103.
125. Walker, E. F., & Lawine, R. J. (1990). Prediction of adult-onset schizophrenia from childhood home movies of patients. American Journal of Psychiatry, 147, 1052-1056.
126. Yung, A. R., & McGorry, P. D. (1996a). Initial prodrome in psychosis: Descriptive and qualitative aspects. Australian and New Zealand Journal of Psychiatry, 30, 587-599.
127. Yung, A. R., & McGorry, P. D. (1996b). The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophrenia Bulletin, 22, 353-370.
128. Yung, A. R., & McGorry, P. D. (1997). Is pre-psychotic intervention realistic in schizophrenia and related disorders? Australian and New Zealand Journal of Psychiatry, 31, 799-805.
129. Yung, A. R., McGorry, P. D., McFarlane, C. A., Jackson, H. J., Patton, G. C., & Rakkar, A. (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22(2), 283-303.
130. Yung, A. R., Phillips, L. J., McGorry, P. D., McFarlane, C. A., Francey, S., Harrigan, S., Patton, G., & Jackson, H. J. (1998). Prediction of psychosis. British Journal of Psychiatry, 33(Suppl. 172), 14-20.
131. Yung, A. P., & Stanley, P. A. (1989). Fever and maculopapular rash. In P. Kincaid-Smith, R. Larkins & G. Whelan (Eds.), Problems in clinical medicine (pp. 335-340). Sydney: MacLennan and Petty.
132. Yung, A. R., Yuen, H. P., Phillips, L. J., Francey, S., & McGorry, P. D. (2003). Mapping the onset of psychosis: The comprehensive assessment of at risk mental states (CAARMS). Schizophrenia Research, 60(1), 30-31.
133. Zammit, S., Allebeck, P., & Andreassen, S. (2002). Self-reported cannabis use as a risk factor for schizophrenia: Further analysis of the 1969 Swedish conscript cohort. British Medical Journal, 325, 1199-1201.
134. Zubin, J., & Spring, B. (1977). Vulnerability: A new view of schizophrenia. Journal of Abnormal Psychology, 86, 103-126.